 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- stavudine / Generic mfg., zidovudine / Generic mfg.
Trial completion, HEOR, Cost effectiveness: Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy (clinicaltrials.gov) - Nov 24, 2014
P4, N=68, Completed, Sponsor: Tufts University
Recruiting --> Completed
- stavudine / Generic mfg., zidovudine / Generic mfg.
Trial completion date, HEOR, Cost effectiveness: Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy (clinicaltrials.gov) - May 6, 2014
P4, N=70, Recruiting, Sponsor: Tufts University
Recruiting --> Completed Trial completion date: Jun 2014 --> Aug 2014
- stavudine / Generic mfg., zidovudine / Generic mfg.
Trial primary completion date, HEOR, Cost effectiveness: Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy (clinicaltrials.gov) - May 6, 2014
P4, N=70, Recruiting, Sponsor: Tufts University
Trial completion date: Jun 2014 --> Aug 2014 Trial primary completion date: Mar 2014 --> Aug 2014
- stavudine / Generic mfg., zidovudine / Generic mfg.
Enrollment open, HEOR, Cost effectiveness: Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy (clinicaltrials.gov) - Dec 16, 2012
P4, N=70, Recruiting, Sponsor: Tufts University
Trial primary completion date: Mar 2014 --> Aug 2014 Not yet recruiting --> Recruiting
- | stavudine / Generic mfg., zidovudine / Generic mfg.
New P4 trial, HEOR, Cost effectiveness: Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy (clinicaltrials.gov) - Sep 24, 2012
P4, N=70, Recruiting, Sponsor: Tufts University